Azelon Therapeutics' Series B Round

Azelon Therapeutics raised a round of funding on May 06, 2005.

Azelon Pharmaceuticals, formerly Zelos Therapeutics, is developing a nasal spray formulation of teriparatide for the treatment of osteoporosis.…

Articles about Azelon Therapeutics' Series B Round: